KEGG   PATHWAY: pleu05150
Entry
pleu05150                   Pathway                                
Name
Staphylococcus aureus infection - Peromyscus leucopus (white-footed mouse)
Description
Staphylococcus aureus can cause multiple forms of infections ranging from superficial skin infections to food poisoning and life-threatening infections. The organism has several ways to divert the effectiveness of the immune system: secreting immune modulating proteins that inhibit complement activation and neutrophil chemotaxis or lysis, modulating the sensitivity to cationic antimicrobial peptides (such as defensin) by increasing the positive net charge of its cytoplasmic membrane, and expression of superantigens that prevent development of a normal immune response or cause an emetic response when ingested.
Class
Human Diseases; Infectious disease: bacterial
Pathway map
pleu05150  Staphylococcus aureus infection
pleu05150

Disease
H00330  Methicillin-resistant Staphylococcal aureus (MRSA) infection
H00331  Vancomycin-resistant Staphylococcal aureus (VRSA) infection
H01409  Methicillin-sensitive Staphylococcus aureus (MSSA) infection
Organism
Peromyscus leucopus (white-footed mouse) [GN:pleu]
Gene
114681439  C5ar1; C5a anaphylatoxin chemotactic receptor 1 [KO:K04010]
114681468  [KO:K03991]
114682367  [KO:K06498]
114682718  Cfi; LOW QUALITY PROTEIN: complement factor I [KO:K01333] [EC:3.4.21.45]
114682943  Fgg; fibrinogen gamma chain [KO:K03905]
114683503  C3ar1; LOW QUALITY PROTEIN: C3a anaphylatoxin chemotactic receptor [KO:K04009]
114684101  Cfd; complement factor D [KO:K01334] [EC:3.4.21.46]
114684899  [KO:K04004]
114685191  Fpr1; fMet-Leu-Phe receptor [KO:K04172]
114685192  Fpr2; N-formyl peptide receptor 2 [KO:K04173]
114686198  Selplg; LOW QUALITY PROTEIN: P-selectin glycoprotein ligand 1 [KO:K06544]
114686347  [KO:K06752]
114686357  [KO:K06752]
114686361  [KO:K06752]
114686362  [KO:K06752]
114686363  [KO:K06752]
114686534  C3; complement C3 isoform X1 [KO:K03990]
114687926  [KO:K06513]
114688156  [KO:K04004]
114688881  [KO:K05230]
114688882  [KO:K05230]
114688883  [KO:K05230]
114688885  [KO:K05230]
114688886  [KO:K05230]
114689124  [KO:K06752]
114689125  [KO:K06752]
114689198  [KO:K05230]
114689890  Fcgr2b; low affinity immunoglobulin gamma Fc region receptor II-b isoform X3 [KO:K12560]
114689891  [KO:K06463]
114690001  [KO:K06496]
114691365  Plg; plasminogen [KO:K01315] [EC:3.4.21.7]
114695207  Icam1; intercellular adhesion molecule 1 isoform X1 [KO:K06490]
114695926  [KO:K03991]
114696529  Itgb2; integrin beta-2 [KO:K06464]
114696565  Krt18; keratin, type I cytoskeletal 18 [KO:K07604]
114697103  Masp1; mannan-binding lectin serine protease 1 isoform X1 [KO:K03992] [EC:3.4.21.-]
114697210  C1qa; complement C1q subcomponent subunit A [KO:K03986]
114697211  C1qc; complement C1q subcomponent subunit C [KO:K03988]
114697212  C1qb; complement C1q subcomponent subunit B [KO:K03987]
114698039  Il10; interleukin-10 [KO:K05443]
114700344  [KO:K06464]
114701851  [KO:K05230]
114701852  [KO:K05230]
114701857  Defb1; beta-defensin 1 [KO:K23125]
114701859  [KO:K21100]
114701864  [KO:K05230]
114701865  [KO:K05230]
114701866  [KO:K05230]
114701867  [KO:K05230]
114701868  [KO:K05230]
114701869  [KO:K23125]
114701872  [KO:K23126]
114704367  Itgal; integrin alpha-L isoform X1 [KO:K05718]
114704404  [KO:K06461]
114704700  C5; complement C5 [KO:K03994]
114704995  Dsg1; desmoglein-1 [KO:K07596]
114705253  [KO:K13916]
114705818  [KO:K06752]
114705822  [KO:K06752]
114705823  [KO:K06752]
114705840  [KO:K06752]
114705842  [KO:K06752]
114705843  [KO:K06752]
114705860  [KO:K03989]
114705865  C2; complement C2 [KO:K01332] [EC:3.4.21.43]
114705866  Cfb; complement factor B [KO:K01335] [EC:3.4.21.47]
114705896  [KO:K06752]
114705956  Ptafr; platelet-activating factor receptor [KO:K04279]
114706915  Krt35; keratin, type I cuticular Ha5 [KO:K07604]
114706917  [KO:K07604]
114706922  [KO:K07604]
114706925  [KO:K07604]
114706930  [KO:K07604]
114706932  Krt24; keratin, type I cytoskeletal 24 [KO:K07604]
114706933  Krt25; keratin, type I cytoskeletal 25 [KO:K07604]
114706935  Krt15; keratin, type I cytoskeletal 15 [KO:K07604]
114706937  Krt20; keratin, type I cytoskeletal 20 [KO:K07604]
114706938  Krt28; keratin, type I cytoskeletal 28 [KO:K07604]
114706941  [KO:K07604]
114706942  [KO:K07604]
114706945  Krt13; keratin, type I cytoskeletal 13 [KO:K07604]
114706948  Krt34; keratin, type I cuticular Ha4 [KO:K07604]
114706949  [KO:K07604]
114706950  Krt23; keratin, type I cytoskeletal 23 [KO:K07604]
114706951  [KO:K07604]
114706953  Krt12; LOW QUALITY PROTEIN: keratin, type I cytoskeletal 12 [KO:K07604]
114706955  Krt27; keratin, type I cytoskeletal 27 [KO:K07604]
114706958  Krt40; keratin, type I cytoskeletal 40 [KO:K07604]
114706970  Krt26; keratin, type I cytoskeletal 26 [KO:K07604]
114706971  Krt39; keratin, type I cytoskeletal 39 [KO:K07604]
114706977  Krt9; keratin, type I cytoskeletal 9 [KO:K07604]
114706978  [KO:K07604]
114706979  Krt19; keratin, type I cytoskeletal 19 [KO:K07604]
114707007  Krt10; keratin, type I cytoskeletal 10 isoform X2 [KO:K07604]
114707193  [KO:K04004]
114708804  C1s; complement C1s subcomponent [KO:K01331] [EC:3.4.21.42]
114708807  C1r; complement C1r subcomponent isoform X1 [KO:K01330] [EC:3.4.21.41]
114709641  Masp2; mannan-binding lectin serine protease 2 isoform X3 [KO:K03993] [EC:3.4.21.104]
114710909  Mbl2; mannose-binding protein C [KO:K03991]
119086087  Fcgr2a; low affinity immunoglobulin gamma Fc region receptor II-a isoform X1 [KO:K06472]
119089186  [KO:K05230]
119089187  [KO:K05230]
Compound
C11596  FMLP
C20898  Lipoteichoic acid
Reference
  Authors
Foster TJ
  Title
Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion.
  Journal
Vet Dermatol 20:456-70 (2009)
DOI:10.1111/j.1365-3164.2009.00825.x
Reference
  Authors
Foster TJ
  Title
Immune evasion by staphylococci.
  Journal
Nat Rev Microbiol 3:948-58 (2005)
DOI:10.1038/nrmicro1289
Reference
  Authors
Laarman A, Milder F, van Strijp J, Rooijakkers S
  Title
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
  Journal
J Mol Med 88:115-20 (2010)
DOI:10.1007/s00109-009-0572-y
Reference
  Authors
Rooijakkers SH, van Kessel KP, van Strijp JA
  Title
Staphylococcal innate immune evasion.
  Journal
Trends Microbiol 13:596-601 (2005)
DOI:10.1016/j.tim.2005.10.002
Reference
  Authors
Iwatsuki K, Yamasaki O, Morizane S, Oono T
  Title
Staphylococcal cutaneous infections: invasion, evasion and aggression.
  Journal
J Dermatol Sci 42:203-14 (2006)
DOI:10.1016/j.jdermsci.2006.03.011
Reference
  Authors
Torres BA, Kominsky S, Perrin GQ, Hobeika AC, Johnson HM
  Title
Superantigens: the good, the bad, and the ugly.
  Journal
Exp Biol Med (Maywood) 226:164-76 (2001)
DOI:10.1177/153537020122600303
Reference
  Authors
Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins AT, Feil EJ, van den Elsen JM
  Title
S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
  Journal
Mol Immunol 45:1600-11 (2008)
DOI:10.1016/j.molimm.2007.10.021
Reference
  Authors
Silverman GJ, Goodyear CS
  Title
Confounding B-cell defences: lessons from a staphylococcal superantigen.
  Journal
Nat Rev Immunol 6:465-75 (2006)
DOI:10.1038/nri1853
Reference
  Authors
Goodyear CS, Silverman GJ
  Title
Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.
  Journal
Proc Natl Acad Sci U S A 101:11392-7 (2004)
DOI:10.1073/pnas.0404382101
Reference
  Authors
Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF
  Title
The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.
  Journal
PLoS Pathog 4:e1000250 (2008)
DOI:10.1371/journal.ppat.1000250
Reference
  Authors
Bokarewa MI, Jin T, Tarkowski A
  Title
Staphylococcus aureus: Staphylokinase.
  Journal
Int J Biochem Cell Biol 38:504-9 (2006)
DOI:10.1016/j.biocel.2005.07.005
Reference
  Authors
Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA
  Title
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
  Journal
Nat Immunol 6:920-7 (2005)
DOI:10.1038/ni1235
Reference
  Authors
Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P
  Title
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
  Journal
Nat Immunol 10:721-7 (2009)
DOI:10.1038/ni.1756
Reference
  Authors
Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH
  Title
Staphylococcal complement evasion by various convertase-blocking molecules.
  Journal
J Exp Med 204:2461-71 (2007)
DOI:10.1084/jem.20070818
Reference
  Authors
Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM
  Title
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.
  Journal
J Infect Dis 198:125-33 (2008)
DOI:10.1086/588825
Reference
  Authors
Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ
  Title
Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
  Journal
FEMS Microbiol Lett 258:290-6 (2006)
DOI:10.1111/j.1574-6968.2006.00229.x
Reference
  Authors
Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR
  Title
Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.
  Journal
Proc Natl Acad Sci U S A 107:3681-6 (2010)
DOI:10.1073/pnas.0910565107
Reference
  Authors
Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD
  Title
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
  Journal
Proc Natl Acad Sci U S A 104:15051-6 (2007)
DOI:10.1073/pnas.0706028104
Reference
  Authors
de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA
  Title
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
  Journal
J Exp Med 199:687-95 (2004)
DOI:10.1084/jem.20031636
Reference
  Authors
Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP
  Title
A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
  Journal
J Immunol 177:8017-26 (2006)
DOI:10.4049/jimmunol.177.11.8017
Reference
  Authors
Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ
  Title
Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling.
  Journal
Blood 109:2936-43 (2007)
DOI:10.1182/blood-2006-06-015461
Reference
  Authors
Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD
  Title
The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.
  Journal
Mol Microbiol 66:1342-55 (2007)
DOI:10.1111/j.1365-2958.2007.05989.x
Reference
  Authors
Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT
  Title
Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes.
  Journal
Nat Med 8:687-93 (2002)
DOI:10.1038/nm728
Reference
  Authors
Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M
  Title
Gram-positive three-component antimicrobial peptide-sensing system.
  Journal
Proc Natl Acad Sci U S A 104:9469-74 (2007)
DOI:10.1073/pnas.0702159104
Reference
  Authors
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J
  Title
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.
  Journal
Antimicrob Agents Chemother 48:4673-9 (2004)
DOI:10.1128/AAC.48.12.4673-4679.2004
Reference
  Authors
Fraser JD, Proft T
  Title
The bacterial superantigen and superantigen-like proteins.
  Journal
Immunol Rev 225:226-43 (2008)
DOI:10.1111/j.1600-065X.2008.00681.x
Reference
  Authors
Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T, Ohara M, Komatsuzawa H, Amagai M, Sugai M
  Title
Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.
  Journal
Infect Immun 70:5835-45 (2002)
DOI:10.1128/IAI.70.10.5835-5845.2002
Reference
  Authors
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J
  Title
Human beta-defensins.
  Journal
Cell Mol Life Sci 63:1294-313 (2006)
DOI:10.1007/s00018-005-5540-2
Reference
  Authors
Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB
  Title
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
  Journal
J Clin Invest 115:2855-61 (2005)
DOI:10.1172/JCI25429
Reference
  Authors
Lehrer RI
  Title
Primate defensins.
  Journal
Nat Rev Microbiol 2:727-38 (2004)
DOI:10.1038/nrmicro976
Related
pathway
pleu04610  Complement and coagulation cascades
pleu04660  T cell receptor signaling pathway
pleu04662  B cell receptor signaling pathway
KO pathway
ko05150   

DBGET integrated database retrieval system